Published in J Intern Med on June 01, 2004
Gains and losses of warfarin therapy as performed in an anticoagulation clinic. J Intern Med (2006) 2.02
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem (1997) 1.67
Incidence of Candida albicans in women using oral contraceptives. Acta Obstet Gynecol Scand (1970) 1.66
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost (2011) 1.61
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res (2010) 1.59
Four-strand hamstring tendon autograft compared with patellar tendon-bone autograft for anterior cruciate ligament reconstruction. A randomized study with two-year follow-up. Am J Sports Med (2001) 1.54
Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer (2005) 1.40
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer (2009) 1.40
[From science to clinical practice. Risk assessment in relation to treatment and prevention]. Ugeskr Laeger (1999) 1.39
Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro. Br J Vener Dis (1976) 1.35
Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br J Cancer (2011) 1.32
Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul (1995) 1.31
Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs. Diabetologia (2007) 1.29
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem (1999) 1.28
Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer (2007) 1.26
Telemedicine used for remote prehospital diagnosing in patients suspected of acute myocardial infarction. J Intern Med (2002) 1.23
Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut (2002) 1.22
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer (2011) 1.16
Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg (2001) 1.12
HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish county. Scand J Prim Health Care (2001) 1.11
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart (2009) 1.04
Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue doppler and three-dimensional echocardiographic study. Cardiology (2001) 1.02
Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene (2011) 1.01
Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. Thromb Haemost (2013) 0.98
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma. Br J Cancer (2010) 0.98
Patients' attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med (1997) 0.96
Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation (2001) 0.96
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene (2011) 0.96
Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots. Clin Chem (1997) 0.95
Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis (2001) 0.93
Use and validation of public data files for identification of the diabetic population in a Danish county. Dan Med Bull (2001) 0.93
Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chim Acta (1994) 0.92
[Cross-sectional therapeutic programs--an example of a cooperative health care system. A review with comments]. Ugeskr Laeger (1998) 0.89
The effect of chronic exposure to fatty acids on gene expression in clonal insulin-producing cells: studies using high density oligonucleotide microarray. Endocrinology (2001) 0.87
C-reactive protein in general practice--how commonly is it used and why? Scand J Prim Health Care (1997) 0.87
Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure. Heart (2001) 0.87
Survey radiography of abdomen following caesarean section, with particular reference to caecal diameter and the presence of free subdiaphragmatic gas. Acta Obstet Gynecol Scand (1976) 0.86
Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand (1986) 0.86
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma. Br J Cancer (2012) 0.86
Magnesium inhibits platelet activity--an in vitro study. Thromb Haemost (1996) 0.86
Magnesium inhibits platelet activity--an infusion study in healthy volunteers. Thromb Haemost (1996) 0.86
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. Eur Heart J (2008) 0.85
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer. Br J Cancer (2013) 0.85
The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III. Scand J Urol Nephrol (1985) 0.84
Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients. J Intern Med (2004) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms. Clin Genet (2012) 0.84
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease. Thromb Haemost (2014) 0.83
Remote ischemic preconditioning reduces thrombus formation in the rat. J Thromb Haemost (2012) 0.83
Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line. Br J Cancer (2001) 0.83
n-3 fatty acids and renal diseases. Am J Kidney Dis (1994) 0.83
Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity in stimulated human T-lymphocytes. Clin Genet (2000) 0.83
Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia. Mutations in brief no. 135. Online. Hum Mutat (1998) 0.83
Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy. Scand J Gastroenterol (1988) 0.83
[Diagnostic value of C-reactive protein in bacterial infections. Review of the literature]. Ugeskr Laeger (1998) 0.83
Myocardial infarction centres: the way forward. Heart (2005) 0.82
Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries. Arterioscler Thromb Vasc Biol (1997) 0.82
Functional analysis of the mismatch repair system in bladder cancer. Br J Cancer (2001) 0.82
Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol (1998) 0.81
Flow cytometric assessment of LDL receptor activity in peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia. Cytometry (1999) 0.81
LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia. Clin Genet (2002) 0.81
Sex-hormone-binding globulin deficiency. Lancet (1982) 0.81
Cigarette smoking shortens the bleeding time. Thromb Res (1983) 0.80
Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol (1997) 0.80
Glycosylation of the N-terminal potential N-glycosylation sites in the human alpha1,3-fucosyltransferase V and -VI (hFucTV and -VI). Glycoconj J (2000) 0.80
Preoperative clindamycin treatment and vaginal drainage in hysterectomy. Acta Obstet Gynecol Scand (1989) 0.80
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation. Thromb Res (1998) 0.80
The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery (1988) 0.80
Plasma concentration levels of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in Greenland Inuit (Eskimos). J Intern Med (1992) 0.79
Radiofrequency ablation of atrial fibrillation: effectiveness and safety in 102 consecutive patients. Heart (2005) 0.79
Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases. Int J Legal Med (2012) 0.79
P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia. Atherosclerosis (1999) 0.79
Intravenous magnesium does not influence the activity of the coagulation cascade. Blood Coagul Fibrinolysis (2001) 0.79
Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium? Nephron (1985) 0.79
Urodynamic evaluation after vaginal repair and colposuspension. Br J Urol (1982) 0.78
[Attitude of patients toward detection of hereditary disease. Heterozygote familial hypercholesterolemia]. Ugeskr Laeger (1998) 0.78
The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis (1993) 0.78
The role of mismatch repair in small-cell lung cancer cells. Eur J Cancer (2003) 0.78
High on-treatment platelet reactivity and P2Y12 antagonists in clinical trials. Thromb Haemost (2012) 0.78
Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology (1993) 0.78
Should patients with acute ST elevation MI be transferred for primary PCI? Heart (2004) 0.78
Enalapril and exercise-induced hyperkalemia. A study of patients randomized to double-blind treatment with enalapril or placebo after acute myocardial infarction. Int J Cardiol (1992) 0.78
[Anticoagulant treatment]. Ugeskr Laeger (2000) 0.78
From science to everyday clinical practice. Need for systematic evaluation of research findings. Scand J Prim Health Care (1999) 0.78
Serum corticotrophin, plasma cortisol and urinary excretion of 17-ketogenic steroids in the elderly (age group: 66-94 years). Acta Endocrinol (Copenh) (1971) 0.78
Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia. Clin Chem (1998) 0.78
Nitroglycerin prolongs the bleeding time in healthy males. Thromb Res (1983) 0.77
A frequent HhaI polymorphism in intron 9 of the low density lipoprotein receptor gene detected by the denaturing gradient gel electrophoresis technique. Clin Genet (1995) 0.77
The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. Thromb Res (1998) 0.77
Magnesium inhibits human platelets. Blood Coagul Fibrinolysis (1996) 0.77
A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy. J Intern Med (2002) 0.77
Ovarian pregnancy. Report of a case with Lippe's loop in situ. Acta Obstet Gynecol Scand (1970) 0.77
Fish oil in angina pectoris. Atherosclerosis (1987) 0.77
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. Thromb Res (2001) 0.77
Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population. Clin Genet (1996) 0.77